The risk of dementia, disease progression and its impact on survival
The risk of dementia, disease progression and its impact on survival
批准号:
7969916
负责人:
Binbing Yu
金额:
$26.99万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AccelerationAgeAge of OnsetAgingAlzheimer&aposs DiseaseAsiaBlood TestsCessation of lifeClinicalCognitiveComparative StudyConsensusDataDementiaDiagnosisDisease ProgressionDropsEducationEducational BackgroundElderlyEvaluationEventGeriatricsHeartHeart DiseasesImageImpaired cognitionIncidenceJapanJapanese AmericanJointsLeftLifeMarkov ChainsMethodsModelingMonte Carlo MethodNeurologistParticipantPhysiciansPrevalenceProceduresProcessProspective StudiesPublic HealthQuality of lifeRiskRisk FactorsSamplingScreening procedureStatistical MethodsStrokeSubgroupSurvivorsTestingTimeUnited StatesWorkbasecognitive functioncognitive reservecohortdesigndisabilityearly onsetfallsfollow-uphazardhealthy aginginstrumentmarkov modelmeetingsmembermenmiddle agemortalitynormal agingprogramstheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Study Data: The Honolulu Heart Program (HHP) is a prospective study of heart disease and stroke involving a cohort of Japanese-American men born between 1900 and 1919. Clinical and demographic information were collected during three midlife examinations (EX) in 1965 (EX1), 1968 through 1970 (EX2), and 1971 through 1974 (EX3). As an extension of the HHP, the Honolulu Asia Aging Study (HAAS) was started in 1991 to study dementia prevalence, incidence and risk factors. At the first HAAS exam (examination 4), 3,734 members of the HHP cohort (80 percent of survivors) participated. Subsequent follow-up examinations for dementia were conducted in 1994 (EX5), 1996-1997 (EX6) and 1999-2000 (EX7) using a multistep procedure. The 100-point Cognitive Abilities Screening Instrument (CASI) was used to screen the entire sample. The CASI is a cross-culturally validated test of global cognitive function designed for use in comparative studies of dementia in the United States and Japan. In EX 4, CASI score and age were used to identify a subgroup of participants for dementia evaluation. In follow-up examinations, subjects with either CASI scores falling below education-adjusted cut-points (77 for participants with low education and 79 for high education) or with absolute drops of at least 9 points were included in a subgroup for specific dementia examination. Subjects who met the criteria for dementia underwent neuro-imaging and blood tests for diagnosis of dementia subtype. A consensus diagnosis was reached by the study neurologist and at least two other physicians with expertise in geriatrics and dementia. We used the death data recorded until June 20, 2002 .
Among the 3,734 participants in EX 4, 226 people were diagnosed with dementia, and they were called prevalent cases. There were 135, 112 and 52 incident dementia cases diagnosed at EX 5, 6, and 7, respectively.
Study 1: Estimate age-specific dementia rate and the impact of dementia on survival.
Summary: Early work discussed the age-specific incidence of dementia. Previous approaches either treated deaths simply as censored or did not include any covariates, however. We proposed an illness-death model for survival data with interval-censoring and left-truncation. This approach can include risk factors related to dementia onset and death, and allow semi-Markov models where survival after dementia could depend on dementia onset age. This model can be used to estimate the cumulative risk of developing dementia in the presence of competing risks of death. We applied this method to dementia data to estimate the age-specific and cumulative risks of incident dementia and to examine the effect of major risk factors on dementia onset and death.
Based on the analysis, we found that having dementia and early onset of dementia both significantly increase mortality rate. Having dementia increases the mortality hazard by 7.9-fold.
Study 2: Joint modeling for cognitive trajectory and risk of dementia in the presence of death
Summary: We used a Bayesian change point model to fit the trajectory of cognitive function for demented people as well as that for normal aged people. In real life, aging people are subject to two competing events, e.g., dementia and death without dementia. The majority of people do not develop dementia. In this article, we used a mixture model to fit the survival data with competing risks consisting of dementia onset time after the change point of cognitive function for demented subjects and death time for non-demented subjects. Cognitive trajectories and the survival process were modeled jointly and parameters were estimated using the Markov chain Monte Carlo method. Using data from the HAAS, we showed the trajectories of cognitive function and the effect of several major covariates.
Based on the analysis, we found that for healthy aging subjects, CASI scores decrease gradually from 90 at age 70 to about 60 at age 95. For demented subjects, the change points for accelerated decline are age 72 and 84 for subjects with lower and higher education levels, respectively. For higher educated subjects, acceleration of cognitive decline occurs later but with a faster rate than for lower educated subjects. This finding is consistent with the theory of cognitive reserve. At age 95, all demented subjects have similar cognitive function regardless of education level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estimating relative risks for longitudinal and clustered binary data
-
批准号:8336694
-
项目类别:
-
资助金额:$2.76万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Evaluatiing the accuracy of complex screening or diagnostic procedures
-
批准号:8336693
-
项目类别:
-
资助金额:$41.38万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Regression analysis in the presence of multicollinearity in brain substructures
-
批准号:8554066
-
项目类别:
-
资助金额:$4.95万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Estimating relative risks for longitudinal and clustered binary data
-
批准号:8554065
-
项目类别:
-
资助金额:$4.95万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Evaluatiing the accuracy of complex screening or diagnostic procedures
-
批准号:8554064
-
项目类别:
-
资助金额:$74.31万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Evaluation of biomarkers and screening tests in the disease diagnosis
-
批准号:7969914
-
项目类别:
-
资助金额:$40.49万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
The risk of dementia, disease progression and its impact on survival
-
批准号:7732395
-
项目类别:
-
资助金额:$22.39万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Evaluation of accuracy of screening tests in disease diagnosis
-
批准号:8149668
-
项目类别:
-
资助金额:$36.9万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Predicting County-Level Cancer Incidence Rates and Counts in the United States
-
批准号:8149669
-
项目类别:
-
资助金额:$22.14万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
Evaluation of biomarkers and screening tests in the disease diagnosis
-
批准号:7732394
-
项目类别:
-
资助金额:$33.58万
-
财政年份:--
-
负责人:Binbing Yu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: